Effect of influenza vaccine on markers of inflammation and lipid profile

Journal of Laboratory and Clinical Medicine

Volumn 145, Issue 6, 2005, Pages 323-327

  Tsai, Michael Y ^a   Hanson, Naomi Q ^b   Straka, Robert J ^b   Hoke, Tracy R ^b   Ordovas, Jose M ^b   Peacock, James M ^b   Arends, Valerie L ^b   Arnett, Donna K ^b  

^a Mayo Mail Code 609   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INFLUENZA VACCINE; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; SERUM AMYLOID A; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; INFLAMMATION; INFLUENZA VACCINATION; INTERMETHOD COMPARISON; MALE; NORMAL HUMAN; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; TIME SERIES ANALYSIS;

ADULT; ANTILIPEMIC AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERLEUKIN-6; LIPIDS; MALE; MIDDLE AGED; PROCETOFEN; RISK FACTORS; TRIGLYCERIDES;

EID: 20644434917     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lab.2005.03.009     Document Type: Article

References (16)

1. B. Reinhardt, R. Jaspert, M. Niedrig, C. Kostner, J. L'age-Stehr Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D a model of human flavivirus infection J Med Virol 56 1998 159 167
2. U.T. Hacker, T. Jelinek, S. Erhardt In vivo synthesis of tumor necrosis factor-alpha in healthy humans after live yellow fever vaccination J Infect Dis 177 1998 774 778
3. M.T. van der Beek, L.G. Visser, M.P. de Maat Yellow fever vaccination as a model to study the response to stimulation of the inflammation system Vascul Pharmacol 39 2002 117 121
4. D. Posthouwer, H.A. Voorbij, D.E. Grobbee, M.E. Numans, J.G. van der Bom Influenza and pneumococcal vaccination as a model to assess C-reactive protein response to mild inflammation Vaccine 23 2004 362 365
5. T.A. Pearson, G.A. Mensah, R.W. Alexander Markers of inflammation and cardiovascular disease. Application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511
6. B.M. Forman, R.M. Evans Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors [α] and [δ] Proc Natl Acad Sci U S A 94 1997 4312 4317
7. B. Staels, J. Dallongeville, J. Auwerx, K. Schoonjans, E. Leitersdorf, J.C. Fruchart Mechanism of action of fibrates on lipid and lipoprotein metabolism Circulation 98 1998 2088 2093
8. B. Staels, W. Koenig, A. Habib Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators Nature 393 1998 790 793
9. N. Marx, J. Plutzky PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule 1 expression in human endothelial cells Circulation 99 1999 3125 3131
10. N. Marx, J. Plutzky PPARalpha activators inhibit tissue factor expression and activity in human monocytes Circulation 103 2001 213 219
11. R.P. Tracy, R.N. Lemaitre, B.M. Psaty Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project Arterioscler Thromb Vasc Biol 17 1997 1121 1127
12. P.M. Ridker, J.E. Buring, J. Shih, M. Matias, C.H. Hennekens Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women Circulation 98 1998 731 733
13. W. Koenig, M. Sund, M. Frohlich C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992 Circulation 99 1999 237 242
14. T.E. Strandberg, R.S. Tilvis C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly Arterioscler Thromb Vasc Biol 20 2000 1057 1060
15. J.T. Whicher, R.E. Chambers, J. Higginson, L. Nashef, P.G. Higgins Acute phase response of serum amyloid A protein and C reactive protein to the common cold and influenza J Clin Pathol 38 1985 312 316
16. T. Nakayama, S. Sonoda, T. Urano, T. Yamada, M. Okada Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infectious diseases Clin Chem 39 1993 293 297